
Keywords: cRGD; brain-targeting drug delivery system; monocyte; depression; trefoil factor 3; cRGD; cyclic RGD; cRGDL; cRGD-modified liposomes; TFF3; trefoil factor 3; cRGDL-TFF3; cRGD liposomes loaded with TFF3; BBB; blood-brain barrier; i.p; intraperitoneal; HBME